Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00286169
Status:
TERMINATED
Last Update Posted:
2022-04-12
First Post:
2006-02-01
Brief Title:
Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer ED-SCLC
Sponsor:
Sumitomo Pharma Co Ltd
Organization:
Sumitomo Pharma Co Ltd
Organization Data
Organization:
Sumitomo Pharma Co Ltd
Class:
INDUSTRY
Study ID:
D0702002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sumitomo Pharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None